María Laura Barreiro Arcos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
María Laura Barreiro Arcos has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Anesini
Department of Pharmacognosy, Faculty of Pharmacy and Biochemistry, IQUIMEFA UBA CONICET, University of Buenos Aires, Buenos Aires, Argentina
3 shared publications - Graciela Alicia Cremaschi
Consejo Nacional de Investigaciones Científicas y Técnicas, Pontificia Universidad Católica Argentina
3 shared publications Horacio Eduardo Romeo
School of Engineering and Agrarian Sciences, Institute of Biomedical Research (BIOMED-UCA-CONICET), Pontifical Catholic University of Argentina, Av. Alicia Moreau de Justo 1600, Buenos Aires, C1107AAZ, Argentina
3 shared publications- Carla Marrassini
Department of Pharmacognosy, Faculty of Pharmacy and Biochemistry, IQUIMEFA UBA CONICET, University of Buenos Aires, Buenos Aires, Argentina
2 shared publications - María Rosario Alonso
Department of Pharmacognosy, Faculty of Pharmacy and Biochemistry, IQUIMEFA UBA CONICET, University of Buenos Aires, Buenos Aires, Argentina
2 shared publications A J Klecha
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (4) , 311-320
Anti-Inflammatory Effect of Urtica urens on LPS-Challenged Keratinocytes
Carla Marrassini, María Laura Barreiro Arcos, Laura Cogoi, María Rosario Alonso, Claudia Anesini. J Pharmacopuncture 2025;28:311-20. https://doi.org/10.3831/KPI.2025.28.4.311
- 31 December 2025
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 28 (4) , 311-320
Open AccessAnti-Inflammatory Effect of Urtica urens on LPS-Challenged Keratinocytes
Carla Marrassini, María Laura Barreiro Arcos, Laura Cogoi, María Rosario Alonso, Claudia Anesini. J Pharmacopuncture 2025;28:311-20. https://doi.org/10.3831/KPI.2025.28.4.311
- Open Access
- 1 January 2025
- Published by Tech Science Press in BIOCELL
- Vol. 49 (4) , 629-646
Hyperthyroidism-Induced Lymphoid Cell Activation in the Lymph Nodes and Spleen of BALB/c Mice
Introduction: Hyperthyroidism is known to affect various physiological systems, including the immune system. Thyroid hormones (THs) play a crucial role in regulating immune function, and alterations in THs levels can lead to immune dysregulation. Objective: Currently, we aimed to elucidate the effects of hyperthyroidism on immune function in BALB/c mice, with a focus on anatomical and histological changes in lymphoid organs, the immune response to mitogenic stimulation, mitochondrial dynamics, and reactive oxygen species (ROS) production. Methods: Hyperthyroidism was induced in BALB/c mice by administering thyroxine (T4; 14 mg/L) in their drinking water for 30 days. Thyroid function was assessed by measuring triiodothyronine (T3), T4, and Thyroid-Stimulating Hormone (TSH) levels. Lymphoid organ hyperplasia was evaluated through anatomical dissection. Lymphoid responses were analyzed by subcutaneous inoculation with lipopolysaccharide (LPS), followed by histological analysis of lymphoid follicles and evaluation of the morphometric parameters of lymphoid cells using flow cytometry. In vitro cell proliferation was quantified using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Mitochondrial morphology and density were assessed by Transmission Electron Microscopy (TEM). ROS and superoxide anion (O2−) production were measured using 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) and Nitroblue Tetrazolium (NBT) assays. Results: Hyperthyroid mice exhibited significantly increased T3 and T4 levels, with decreased TSH levels. Lymphoid organs, including the spleen and lymph nodes, were notably enlarged in hyperthyroid mice, with a corresponding increase in lymphoid cell number. LPS stimulation enhanced the number and size of lymphoid follicles, with hyperthyroid mice showing a greater proliferative response. TEM analysis revealed increased mitochondrial density and changes in mitochondrial structure in hyperthyroid lymphoid cells. ROS and O2− production were significantly higher in hyperthyroid mice, though no apoptotic activity was detected. Conclusion: Hyperthyroidism leads to significant alterations in immune responses, including enhanced lymphoid organ size, increased proliferation of immune cells, and elevated ROS production. These findings provide new insights into the immunomodulatory effects of thyroid dysfunction and its potential impact on immune system regulation, offering a deeper understanding of THs interactions with immune activation.
- 1 January 2025
- Published by Tech Science Press in BIOCELL
- Vol. 49 (4) , 629-646
Open AccessHyperthyroidism-Induced Lymphoid Cell Activation in the Lymph Nodes and Spleen of BALB/c Mice
Introduction: Hyperthyroidism is known to affect various physiological systems, including the immune system. Thyroid hormones (THs) play a crucial role in regulating immune function, and alterations in THs levels can lead to immune dysregulation. Objective: Currently, we aimed to elucidate the effects of hyperthyroidism on immune function in BALB/c mice, with a focus on anatomical and histological changes in lymphoid organs, the immune response to mitogenic stimulation, mitochondrial dynamics, and reactive oxygen species (ROS) production. Methods: Hyperthyroidism was induced in BALB/c mice by administering thyroxine (T4; 14 mg/L) in their drinking water for 30 days. Thyroid function was assessed by measuring triiodothyronine (T3), T4, and Thyroid-Stimulating Hormone (TSH) levels. Lymphoid organ hyperplasia was evaluated through anatomical dissection. Lymphoid responses were analyzed by subcutaneous inoculation with lipopolysaccharide (LPS), followed by histological analysis of lymphoid follicles and evaluation of the morphometric parameters of lymphoid cells using flow cytometry. In vitro cell proliferation was quantified using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Mitochondrial morphology and density were assessed by Transmission Electron Microscopy (TEM). ROS and superoxide anion (O2−) production were measured using 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) and Nitroblue Tetrazolium (NBT) assays. Results: Hyperthyroid mice exhibited significantly increased T3 and T4 levels, with decreased TSH levels. Lymphoid organs, including the spleen and lymph nodes, were notably enlarged in hyperthyroid mice, with a corresponding increase in lymphoid cell number. LPS stimulation enhanced the number and size of lymphoid follicles, with hyperthyroid mice showing a greater proliferative response. TEM analysis revealed increased mitochondrial density and changes in mitochondrial structure in hyperthyroid lymphoid cells. ROS and O2− production were significantly higher in hyperthyroid mice, though no apoptotic activity was detected. Conclusion: Hyperthyroidism leads to significant alterations in immune responses, including enhanced lymphoid organ size, increased proliferation of immune cells, and elevated ROS production. These findings provide new insights into the immunomodulatory effects of thyroid dysfunction and its potential impact on immune system regulation, offering a deeper understanding of THs interactions with immune activation.
- 1 January 2024
- Published by Springer Nature
- p. 257-278
Cancer Stem Cells in Lung Cancer, a Novel Frontier
- 1 January 2024
- Published by Springer Nature
- p. 257-278
Cancer Stem Cells in Lung Cancer, a Novel Frontier
- Open Access
- 26 June 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 15 (6) , 576-588
Clinical relevance of stem cells in lung cancer
Clinical relevance of stem cells in lung cancer
- 26 June 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 15 (6) , 576-588
Open AccessClinical relevance of stem cells in lung cancer
Clinical relevance of stem cells in lung cancer
- 2 September 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1866 (12) , 130239
Role of thyroid hormones-induced oxidative stress on cardiovascular physiology
- 2 September 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1866 (12) , 130239
Role of thyroid hormones-induced oxidative stress on cardiovascular physiology
- Open Access
- 30 April 2021
- Published by MS-Editions in Medicinal Plant Communications
- Vol. 4 (2) , 48-55
Aqueous and polyphenol-rich Larrea divaricata Cav. extracts as potential skin care agents
- 30 April 2021
- Published by MS-Editions in Medicinal Plant Communications
- Vol. 4 (2) , 48-55
Open AccessAqueous and polyphenol-rich Larrea divaricata Cav. extracts as potential skin care agents
- Open Access
- 22 August 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-14
Larrea divaricata Cav. aqueous extract and nordihydroguariaretic acid modulate oxidative stress in submandibular glands of diabetic rats: a buccal protective in diabetes
Oxidative stress is an imbalance between the levels of reactive oxygen species (ROS), reactive nitrogen species (RNS) and endogenous antioxidants. The aetiology and pathogenesis of several oral diseases are attributed to this process. The antioxidant enzymes secreted in the saliva by submandibular glands maintain oral health through the scavenging of ROS. The objective of this work was to study the capacity of an aqueous extract of L. divaricata (AE), and its majority compound, nordihydroguariaretic acid (NDGA), to modulate the pro-oxidant/antioxidant status in submandibular glands in a model of oxidative stress induced by streptozotocin (STZ) in rats. To induce oxidative stress with STZ, a group of animals was treated i.p. with 1 X PBS (control group) and other group was injected i.p. once with STZ (60 mg/kg). Ten days after the treatment, blood samples were taken from the tail vain to determine the glucose levels. Animals with glucose values ≥300 mg/ml were selected. The submandibular glands of control and STZ treated animals were incubated with either the AE (500 μg/ml) or with NDGA (1.5 μg/ml), and the content of malondialdehyde (MDA), protein carbonyl groups, ROS and RNS, and the activity and expression of peroxidase (Px), superoxide dismutase (SOD) and inducible nitric oxide synthase (iNOS) were assayed. AE decreased the levels of MDA (##P < 0.01) and protein carbonyl groups (#P < 0.05), and modulated the levels of ROS such as hydrogen peroxide (H2O2)(##P < 0.01), superoxide anion (O2.-) (#P < 0.05) and nitric oxide (NO) (#P < 0.05) in relation to the modulation of Px and iNOS expression. NDGA was found to be involved in these effects. The antioxidant activity of the AE in the submandibular glands would allow the maintenance of the antioxidant pool to prevent oral oxidative diseases.
- 22 August 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-14
Open AccessLarrea divaricata Cav. aqueous extract and nordihydroguariaretic acid modulate oxidative stress in submandibular glands of diabetic rats: a buccal protective in diabetes
Oxidative stress is an imbalance between the levels of reactive oxygen species (ROS), reactive nitrogen species (RNS) and endogenous antioxidants. The aetiology and pathogenesis of several oral diseases are attributed to this process. The antioxidant enzymes secreted in the saliva by submandibular glands maintain oral health through the scavenging of ROS. The objective of this work was to study the capacity of an aqueous extract of L. divaricata (AE), and its majority compound, nordihydroguariaretic acid (NDGA), to modulate the pro-oxidant/antioxidant status in submandibular glands in a model of oxidative stress induced by streptozotocin (STZ) in rats. To induce oxidative stress with STZ, a group of animals was treated i.p. with 1 X PBS (control group) and other group was injected i.p. once with STZ (60 mg/kg). Ten days after the treatment, blood samples were taken from the tail vain to determine the glucose levels. Animals with glucose values ≥300 mg/ml were selected. The submandibular glands of control and STZ treated animals were incubated with either the AE (500 μg/ml) or with NDGA (1.5 μg/ml), and the content of malondialdehyde (MDA), protein carbonyl groups, ROS and RNS, and the activity and expression of peroxidase (Px), superoxide dismutase (SOD) and inducible nitric oxide synthase (iNOS) were assayed. AE decreased the levels of MDA (##P < 0.01) and protein carbonyl groups (#P < 0.05), and modulated the levels of ROS such as hydrogen peroxide (H2O2)(##P < 0.01), superoxide anion (O2.-) (#P < 0.05) and nitric oxide (NO) (#P < 0.05) in relation to the modulation of Px and iNOS expression. NDGA was found to be involved in these effects. The antioxidant activity of the AE in the submandibular glands would allow the maintenance of the antioxidant pool to prevent oral oxidative diseases.
- Open Access
- 2 June 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-14
Oxidative Stress Produced by Hyperthyroidism Status Induces the Antioxidant Enzyme Transcription through the Activation of the Nrf-2 Factor in Lymphoid Tissues of Balb/c Mice
Hyperthyroidism is an endocrine disorder characterized by excessive secretion of thyroid hormones T3 and T4. Thyroid hormones exert pleiotropic actions on numerous tissues and induce an overall increase in metabolism, with an increase in energy demand and oxygen consumption. Therefore, the purpose of this study was to investigate the effects of hyperthyroidism on the production of reactive oxygen species (ROS) in lymph node and spleen cells of euthyroid and hyperthyroid mice, analyzing antioxidant mechanisms involved in the restitution of the cellular redox state. For this, thirty female Balb/c (H-2d) mice were randomly divided into two groups: euthyroid (by treatment with placebo) and hyperthyroid (by treatment with 12 mg/l of T4 in drinking water for 30 days). We found a significant increase in ROS and an increase in the genomic and protein expression of the antioxidant enzymes catalase (CAT) and glutathione peroxidase-1 (GPx-1) in lymph node and spleen cells of hyperthyroid mice. In vitro treatment with H2O2 (250 μM) of the lymphoid cells of euthyroid mice increased the expression levels of CAT and GPx-1. The hyperthyroidism increased the phosphorylation levels of Nrf2 (nuclear factor erythroid 2-related factor) and the kinase activity of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK). Additionally, we found an increase in the expression of the classic isoenzymes of PKCα, β and γ. In conclusion, these results indicated that the increase in ROS found in the hyperthyroid state induces the antioxidant enzyme transcription through the activation of the Nrf-2 factor in lymphoid tissues. This shows the influence of hyperthyroidism on the regulation of the cellular antioxidant system.
- 2 June 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-14
Open AccessOxidative Stress Produced by Hyperthyroidism Status Induces the Antioxidant Enzyme Transcription through the Activation of the Nrf-2 Factor in Lymphoid Tissues of Balb/c Mice
Hyperthyroidism is an endocrine disorder characterized by excessive secretion of thyroid hormones T3 and T4. Thyroid hormones exert pleiotropic actions on numerous tissues and induce an overall increase in metabolism, with an increase in energy demand and oxygen consumption. Therefore, the purpose of this study was to investigate the effects of hyperthyroidism on the production of reactive oxygen species (ROS) in lymph node and spleen cells of euthyroid and hyperthyroid mice, analyzing antioxidant mechanisms involved in the restitution of the cellular redox state. For this, thirty female Balb/c (H-2d) mice were randomly divided into two groups: euthyroid (by treatment with placebo) and hyperthyroid (by treatment with 12 mg/l of T4 in drinking water for 30 days). We found a significant increase in ROS and an increase in the genomic and protein expression of the antioxidant enzymes catalase (CAT) and glutathione peroxidase-1 (GPx-1) in lymph node and spleen cells of hyperthyroid mice. In vitro treatment with H2O2 (250 μM) of the lymphoid cells of euthyroid mice increased the expression levels of CAT and GPx-1. The hyperthyroidism increased the phosphorylation levels of Nrf2 (nuclear factor erythroid 2-related factor) and the kinase activity of protein kinase C (PKC) and extracellular signal-regulated kinase (ERK). Additionally, we found an increase in the expression of the classic isoenzymes of PKCα, β and γ. In conclusion, these results indicated that the increase in ROS found in the hyperthyroid state induces the antioxidant enzyme transcription through the activation of the Nrf-2 factor in lymphoid tissues. This shows the influence of hyperthyroidism on the regulation of the cellular antioxidant system.
- Open Access
- 13 June 2014
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 222 (2) , 243-255
Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
We have shown in vitro that thyroid hormones (THs) regulate the balance between proliferation and apoptosis of T lymphoma cells. The effects of THs on tumor development have been studied, but the results are still controversial. Herein, we show the modulatory action of thyroid status on the in vivo growth of T lymphoma cells. For this purpose, euthyroid, hypothyroid, and hyperthyroid mice received inoculations of EL4 cells to allow the development of solid tumors. Tumors in the hyperthyroid animals exhibited a higher growth rate, as evidenced by the early appearance of palpable solid tumors and the increased tumor volume. These results are consistent with the rate of cell division determined by staining tumor cells with carboxyfluorescein succinimidyl ester. Additionally, hyperthyroid mice exhibited reduced survival. Hypothyroid mice did not differ significantly from the euthyroid controls with respect to these parameters. Additionally, only tumors from hyperthyroid animals had increased expression levels of proliferating cell nuclear antigen and active caspase 3. Differential expression of cell cycle regulatory proteins was also observed. The levels of cyclins D1 and D3 were augmented in the tumors of the hyperthyroid animals, whereas the cell cycle inhibitors p16/INK4A (CDKN2A) and p27/Kip1 (CDKN1B) and the tumor suppressor p53 (TRP53) were increased in hypothyroid mice. Intratumoral and peritumoral vasculogenesis was increased only in hyperthyroid mice. Therefore, we propose that the thyroid status modulates the in vivo growth of EL4 T lymphoma through the regulation of cyclin, cyclin-dependent kinase inhibitor, and tumor suppressor gene expression, as well as the stimulation of angiogenesis.
- 13 June 2014
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 222 (2) , 243-255
Open AccessThyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
We have shown in vitro that thyroid hormones (THs) regulate the balance between proliferation and apoptosis of T lymphoma cells. The effects of THs on tumor development have been studied, but the results are still controversial. Herein, we show the modulatory action of thyroid status on the in vivo growth of T lymphoma cells. For this purpose, euthyroid, hypothyroid, and hyperthyroid mice received inoculations of EL4 cells to allow the development of solid tumors. Tumors in the hyperthyroid animals exhibited a higher growth rate, as evidenced by the early appearance of palpable solid tumors and the increased tumor volume. These results are consistent with the rate of cell division determined by staining tumor cells with carboxyfluorescein succinimidyl ester. Additionally, hyperthyroid mice exhibited reduced survival. Hypothyroid mice did not differ significantly from the euthyroid controls with respect to these parameters. Additionally, only tumors from hyperthyroid animals had increased expression levels of proliferating cell nuclear antigen and active caspase 3. Differential expression of cell cycle regulatory proteins was also observed. The levels of cyclins D1 and D3 were augmented in the tumors of the hyperthyroid animals, whereas the cell cycle inhibitors p16/INK4A (CDKN2A) and p27/Kip1 (CDKN1B) and the tumor suppressor p53 (TRP53) were increased in hypothyroid mice. Intratumoral and peritumoral vasculogenesis was increased only in hyperthyroid mice. Therefore, we propose that the thyroid status modulates the in vivo growth of EL4 T lymphoma through the regulation of cyclin, cyclin-dependent kinase inhibitor, and tumor suppressor gene expression, as well as the stimulation of angiogenesis.